A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
city
~38 mi. (Toluca de Guadalupe, Mexico, +126 more cities)
facility
Phylasis Clinicas Research S. de R.L. de C.V.
drug
nivolumab, +2 more drugs
drug type
chemotherapy, +1 more type
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
city
~47 mi. (Ciudad de Atlixco, Mexico, +271 more cities)
facility
Local Institution
drug
docetaxel, +2 more drugs
drug type
chemotherapy, +2 more types
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer
city
~47 mi. (Ciudad de Atlixco, Mexico, +172 more cities)
facility
Local Institution
drug
cisplatin, +3 more drugs
drug type
chemotherapy, +1 more type
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That Has Invaded the Muscle Wall of the Bladder and Who Cannot Get Cisplatin, a Type of Medicine Given to Treat Bladder Cancer.
city
~47 mi. (Ciudad de Atlixco, Mexico, +137 more cities)
facility
Local Institution
drug
bempegaldesleukin, +2 more drugs
drug type
immunotherapy, +2 more types
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
city
~47 mi. (Ciudad de Atlixco, Mexico, +170 more cities)
facility
Novartis Investigative Site
biomarker
ER Negative, +4 more biomarkers
drug
alpelisib, +1 more drug
drug type
chemotherapy, +1 more type
A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors
city
~47 mi. (Ciudad de Atlixco, Mexico, +60 more cities)
facility
Local Institution
drug
nivolumab, +1 more drug
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~75 mi. (Orizaba, Mexico, +383 more cities)
facility
Clinica Medica Research SC
biomarker
ER Negative, +2 more biomarkers
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
city
~75 mi. (Orizaba, Mexico, +158 more cities)
facility
CLIMERS Clinical Medical Research ( Site 0506)
drug
olaparib, +4 more drugs
drug type
chemotherapy, +3 more types